Literature DB >> 17364631

Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison.

Alice A Hughes1, Gregory M Bogdan, Richard C Dart.   

Abstract

BACKGROUND: Prescription opioids are abused throughout the United States. Several monitoring programs are in existence, however, none of these systems provide up-to-date information on prescription opioid abuse. This article describes the use of poison centers as a real-time, geographically specific, surveillance system for prescription opioid abuse and compares our system with an existing prescription drug abuse monitoring program, the Drug Abuse Warning Network (DAWN).
METHODS: Data were collected from eight geographically dispersed poison centers for a period of twelve months. Any call involving buprenorphine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, and oxycodone was considered a case. Any case coded as intentional exposure (abuse, intentional misuse, suicide, or intentional unknown) was regarded as misuse and abuse. Comparative data were obtained from DAWN.
RESULTS: Poison center rates of abuse and misuse were highest for hydrocodone at 3.75 per 100,000 population, followed by oxycodone at 1.81 per 100,000 population. DAWN emergency department (ED) data illustrate a similar pattern of abuse with most mentions involving hydrocodone and oxycodone. Poison center data indicate that people aged 18 to 25 had the highest rates of abuse. DAWN reported the majority of ED mentions among 35 to 44-year-olds. Geographically, Kentucky had the uppermost rates of abuse and misuse for all opioids combined at 20.69 per 100,000 population. CONCLUSIONS. Comparing poison center data to DAWN yielded mostly comparable results, including hydrocodone as the most commonly mentioned drug. Our results suggest poison center data can be used as an indicator for prescription opioid abuse and misuse and can provide timely, geographically specific information on prescription drug abuse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364631     DOI: 10.1080/15563650600981137

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  11 in total

1.  The value and evolving role of the U.S. Poison Control Center System.

Authors:  Henry A Spiller; Jill R K Griffith
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

2.  Calls managed by the BC Drug and Poison Information Centre following the 2011 nuclear reactor incident at Fukushima, Japan.

Authors:  Monica Durigon; Tom Kosatsky
Journal:  Can Pharm J (Ott)       Date:  2012-11

Review 3.  Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Authors:  Michael A Yokell; Nickolas D Zaller; Traci C Green; Josiah D Rich
Journal:  Curr Drug Abuse Rev       Date:  2011-03

4.  Mental health and emergency medicine: a research agenda.

Authors:  Gregory Luke Larkin; Annette L Beautrais; Anthony Spirito; Barbara M Kirrane; Melanie J Lippmann; David P Milzman
Journal:  Acad Emerg Med       Date:  2009-11       Impact factor: 3.451

5.  Area-level socioeconomic status in relation to outcomes in gamma-hydroxybutyrate intoxication.

Authors:  Ilene B Anderson; Susan Y Kim-Katz; Jo Ellen Dyer; Gillian E Earnest; John P Lamb; Paul D Blanc
Journal:  Clin Toxicol (Phila)       Date:  2009-01       Impact factor: 4.467

6.  Regional variation in the severity of pesticide exposure outcomes: applications of geographic information systems and spatial scan statistics.

Authors:  Daniel L Sudakin; Laura E Power
Journal:  Clin Toxicol (Phila)       Date:  2009-03       Impact factor: 4.467

7.  Using poison center exposure calls to predict methadone poisoning deaths.

Authors:  Nabarun Dasgupta; Jonathan Davis; Michele Jonsson Funk; Richard Dart
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

8.  Challenges in using opioids to treat pain in persons with substance use disorders.

Authors:  Seddon R Savage; Kenneth L Kirsh; Steven D Passik
Journal:  Addict Sci Clin Pract       Date:  2008-06

9.  Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States.

Authors:  Mark A Sembower; Michelle D Ertischek; Chloe Buchholtz; Nabarun Dasgupta; Sidney H Schnoll
Journal:  J Addict Dis       Date:  2013

Review 10.  Guidelines for Opioid Prescribing in Children and Adolescents After Surgery: An Expert Panel Opinion.

Authors:  Lorraine I Kelley-Quon; Matthew G Kirkpatrick; Robert L Ricca; Robert Baird; Calista M Harbaugh; Ashley Brady; Paula Garrett; Hale Wills; Jonathan Argo; Karen A Diefenbach; Marion C W Henry; Juan E Sola; Elaa M Mahdi; Adam B Goldin; Shawn D St Peter; Cynthia D Downard; Kenneth S Azarow; Tracy Shields; Eugene Kim
Journal:  JAMA Surg       Date:  2021-01-01       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.